Wednesday, October 14, 2026

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI premiums for Oura and home builders.

SOLS $9.7BSBUX $109B

Yet Another Value Podcast Oct 14 87 clicks

Oct 14 COHR $52B

Coherent | Management Call

P Equity Research 18 clicks

Oct 14 AMAT $359B

Deep Dive: Applied Materials ($AMAT)

Rebound Capital 30 clicks

From X

@LaughingH20Cap Oct 14 5 clicks

Laughing Water Capital on X

@bufetmastermind @secretlyaninja @mbamcnulty maybe i don't. I'd appreciate if you could explain. they had said 50% FCF margin on $1B in sales. $LQDA is still going to get to $1B in sales. Its just going to take longer. Tell me why 50% FCF margins are not in play. Bonus points if you can tell why they won't reduce costs

@HaydenCapital Oct 14 1 click

Fred Liu on X

Is Tiktok Shop slowing? J&T Express just reported SE Asia parcel volumes, and are flat for the year at ~31M per day for the last few qtrs. They're guiding to 50-55% full year growth, implying Q4 holiday season only ramps to 33-37M parcels. Evidence Shopee's VIP & logistics investments are working? $SE $1519.HK

@hkuppy Oct 14 1 click

Kuppy on X

I’m sure that $CRWV is money good on funding its gazillions of chip purchase orders, as long as someone funds $CRWV…🤭🤭 https://t.co/TOnS6iGurC

@gnoble79 Oct 14 8 clicks

George Noble on X

Keith, you are a total POS. You belong in jail for securities fraud. I own you. You laughed at me first shorting $OOEN at 8. You are such a pathetic, odious pile of garbage. So pathetic. The entire world is laughing at you. Thanks for playing. $OPEN @rabois @ericjackson @APompliano @

@BrokenMoats Oct 14 4 clicks

Broken Moats on X

Hottest trade in the past month.....retail stocks Seems odd with rates and oil and diesel moves over the same time frame. And these are not bounces from being oversold these are double digit moves in most cases to new highs while dpz struggled on their print this week, stocks like DKS collapsed around the time this trade started. Bifurcation in retail in recent weeks that seems to be favoring low quality. Something to watch for a reversal soon $KSS $FIGS $URBN $SHOP

@BlueDuckCap Oct 14 5 clicks

BDC on X

It's been 189 days since @evanspiegel had a confirmed sale. The longest sales void ever, per what we can discern from filings. He's in a blackout window now. If the sales do not resume post Q3 window opening then that would seem bullish. We would love an insider buy, too. Evan buys stock here we would think $SNAP is +10% on that day. At least. Not advice. Just pointing out the cadence of form 4's and lack of historical insider buying.

@ACapitalLP Oct 14 3 clicks

A Capital on X

$KYIV https://t.co/bGd6IJ4Xl0

@BrokenMoats Oct 14 3 clicks

Broken Moats on X

Quickly back to very attractive levels to put back on short exposure on the software sector after the manic move in Q3 and digestion in September before the sudden crash up in the past 10 days..... AI wins software is in trouble - faster disruption more competition, pricing pressure AI trade is over, software is going to catch down as the market will tank and this won't sit that out (the are not cheap) Disruption and pricing is the tailwind, now valuation is too. Rates don't hurt either as up until recently these were considered long duration assets Recent results were status quo for most (no real acceleration) and pitch AI cohort growth as growing xx% but its not uplifting the total growth they are just changing what they charge for to show the street what it wants to hear) -- that phase is over, valuations are in many cases at year and multi year highs. SBC still a problem. Now comes renewals in the back of this year and thats where the issues will start to emerge on retention and pricing. An thats day 1 they will snowball overtime for the vast majority of these companies. Plenty of names to choose from: $PAYC $DOCU $TEAM $DDOG $PCTY $GDDY $RNG

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TEVA $48B

Equity Eagle Oct 14 8 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $88BJBHT $22B

Monte Independent Investment Research Oct 14 14 clicks

Palantir Is Not C3.Ai, But C3.Ai Wrote Its Watch List - Downgrade Palantir To Hold, Sell C3.Ai

Palantir is cut to Hold after a 35% multiple-driven rally, while C3.ai is rated Sell on stalled revenue, expensive valuation and weak…

PLTR $482B

The Alpha Analyst Oct 14 10 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $17B

Latticework by MOI Global Oct 14 14 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B

Latticework by MOI Global Oct 14 15 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B

Latticework by MOI Global Oct 14 13 clicks

Eaton: Strong Backlog And Margin Recovery Support The Buy Case

Eaton’s backlog, data-center, grid and aerospace demand, plus a 450–500 bp H2 2026 Electrical Americas margin recovery, support the growth…

ETN $156B

Value Capital Research Oct 14 7 clicks

Insider activity September 2026

Asian insider buying rose 19% to US$2.4 billion across 930 September transactions, led by Grab CEO Anthony Tan’s US$30 million purchase…

GRAB $12B

Asian Century Stocks Oct 14 7 clicks

Scarcity is the boogey man for ASML, Applied Materials

ASML’s strong quarterly results failed to prevent a selloff, as AI investors focused on scarcity fears facing chip-equipment makers…

AMAT $359B

The Technology Letter Oct 13 8 clicks

Expert Call | Corning

Corning’s NVIDIA-backed 10x fiber expansion, enterprise connector demand and carrier capacity plans frame its optical communications…

GLW $115B

P Equity Research Oct 13 38 clicks

ZTS · long

Zoetis INC

Zoetis, the animal prescription-medicines company, is presented as a long investment despite concerns around its 2026 and 2027 outlook.

ZTS $31B

Value Investors Club May 8 3 clicks

Visa Inc update

Visa and Mastercard meet 15% five-year IRR targets at 25x and 26x 2026 earnings, while American Express needs a wider margin for…

AXP $212B

Global Outperformers Mar 11

We Dramatically Improved our Machine Learning Model to Price Kalshi Earnings Contracts. It Went 11/13.

A two-layer machine-learning model correctly called 11 of 13 CrowdStrike earnings-word contracts on Kalshi, using historical transcripts…

CRWD $233B

First Strike Research Mar 7

Sea Limited (SE) Q4'25 - Shopee in Focus, 11 Reasons To Keep Investing

Sea Limited generated about $3.5 billion in free cash flow as Shopee invests in Southeast Asian and Brazilian growth despite lower 2027…

SE $57B

Sleep Well Investments Mar 6

Single Stock Spotlight #3: Alpha Metallurgical Resources (AMR)

Alpha Metallurgical Resources has retired more than 30% of its shares since 2022; higher structural metallurgical-coal costs could support…

AMR $2.2B

Hidden Rock Capital's Newsletter Mar 3

Kazakhstan, Japan, and Trimming a Winner

Kaspi.kz’s 850 KZT ADS dividend establishes a roughly 9% yield after Hepsiburada spending; Japanese buyback disclosures test whether 0.61x…

KSPI $18B

Cluseau Research Mar 2 2 clicks

Portfolio Update February 2026

Constellation Software and Roper Technologies became 13% and 16% holdings after an AI-driven software selloff, while Ashtead and Kraft…

ROP $36B

D Invests Mar 2

Is the Airline Industry Really That Bad? – AerCap and A Case of Sandbagged Guidance

AerCap sells aircraft at 2x book value and repurchases stock near 1x book, cutting shares outstanding 31% in three years.

AER $23B

Bristlemoon Capital Mar 2 1 click

Sleep Well Portfolio (Feb 2026) - Software AI risk Assessed

Sleep Well Portfolio cuts SPS Commerce after assessing AI risk across 12 software holdings, finding deterministic, rule-based data…

SPSC $3.1B

Sleep Well Investments Mar 2

APi Group: How the story has evolved and what's next

APi Group hit its 13/60/80 targets in 2025, reporting $7.9 billion revenue, 13.2% EBITDA margin and 80% free-cash-flow conversion, then set…

APG $17B

Kairos Research Feb 26

Wednesday, October 14, 2026

Laughing Water Capital on X

Fred Liu on X

Kuppy on X

George Noble on X

Broken Moats on X

BDC on X

A Capital on X

Broken Moats on X

Investor Letters

Publications we follow

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 236

X accounts we follow

Investor letters we follow

Sectors